Chain Drug Review - Doryx DR approved
Related Results
TetracyclinesTetracyclinesNew Uses for an Old Drug: Rebirth of the TetracyclinesTetracycline diffusion through bacterial cellulose—polyvinyl alcohol…Tetracycline Derivative Induces Lupus
> Warner Chilcott Ltd. has received FDA approval for a 150-mg strength of Doryx (doxycycline hyclate) delayed-release tablets. The drug, a tetracycline-class oral antibiotic indicated for adjunctive treatment of severe acne, contains enteric-coated pellets of doxycycline hyclate. The pellets do not release until they reach the small intestine, minimizing the gastrointestinal side effects most commonly associated with other doxycycline products.
COPYRIGHT 2008 Racher Press, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
